Cart
sales@molnova.com
Gly-Gly-OMe.HCl|H-Gly-Gly-OMe.HCl
CAS No. 2776-60-5
Gly-Gly-OMe.HCl|H-Gly-Gly-OMe.HCl( ——— )
Catalog No. M40510 CAS No. 2776-60-5
Gly-Gly-OMe.HCl|H-Gly-Gly-OMe.HCl
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGly-Gly-OMe.HCl|H-Gly-Gly-OMe.HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionGly-Gly-OMe.HCl|H-Gly-Gly-OMe.HCl
-
DescriptionGly-Gly-OMe.HCl|H-Gly-Gly-OMe.HCl
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number2776-60-5
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MYLS22
MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
-
Interleukin-6 Recept...
Interleukin-6 Receptor (partial)
-
RGDV
RGDV is a platelet aggregation inhibitor. RGDV inhibits platelet-dependent thrombus formation. RGDV is used for tumor recognition via the targeting effect.
